Targeting Bruton's tyrosine kinase expression levels through microRNAs in chronic lymphocytic leukemia treatment

被引：1

作者：

Singh, Simar Pal ^{[1
,2
,3
]}

Rip, Jasper ^{[1
]}

Hendriks, Rudi W. ^{[1
]}

机构：

[1] Erasmus MC, Dept Pulm Med, Room Ee2251a,POB 2040, NL-3000 CA Rotterdam, Netherlands

[2] Erasmus MC, Dept Immunol, Rotterdam, Netherlands

[3] Erasmus MC, Post Grad Sch Mol Med, Rotterdam, Netherlands

来源：

TRANSLATIONAL CANCER RESEARCH | 2017年 / 6卷

关键词：

B-CELL ACTIVATION; BTK; IBRUTINIB; INHIBITOR; MECHANISMS; MIR-155; DISEASE; RNA;

D O I：

10.21037/tcr.2017.04.06

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S502 / S507

页数：6

共 25 条

[1] Novel Mechanisms of Regulation of miRNAs in CLL
Balatti, Veronica
Acunzo, Mario
Pekarky, Yuri
Croce, Carlo M.
[J]. TRENDS IN CANCER, 2016, 2 (03): : 134 - 143
[2] MicroRNAs Prevent the Generation of Autoreactive Antibodies
Belver, Laura
de Yebenes, Virginia G.
Ramiro, Almudena R.
[J]. IMMUNITY, 2010, 33 (05) : 713 - 722
[3] Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
Bichi, R
Shinton, SA
Martin, ES
Koval, A
Calin, GA
Cesari, R
Russo, G
Hardy, RR
Croce, CM
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) : 6955 - 6960
[4] Bottoni A, 2016, BLOOD, V128, P3101, DOI [10.1182/blood-2016-07727750, 10.1182/blood-2016-07-727750]
[5] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
Burger, J. A.
Tedeschi, A.
Barr, P. M.
Robak, T.
Owen, C.
Ghia, P.
Bairey, O.
Hillmen, P.
Bartlett, N. L.
Li, J.
Simpson, D.
Grosicki, S.
Devereux, S.
McCarthy, H.
Coutre, S.
Quach, H.
Gaidano, G.
Maslyak, Z.
Stevens, D. A.
Janssens, A.
Offner, F.
Mayer, J.
O'Dwyer, M.
Hellmann, A.
Schuh, A.
Siddiqi, T.
Polliack, A.
Tam, C. S.
Suri, D.
Cheng, M.
Clow, F.
Styles, L.
James, D. F.
Kipps, T. J.
Keating, Michael
Jen, Jie
Jindra, Pavel
Simkovic, Martin
Braester, Andrei
Ruchlemer, Rosa
Foa, Roberto
Semenzato, Gianpietro
Hawkins, Timothy
Atanasio, Carolina Moreno
Demirkan, Fatih
Kaynar, Leylagul
Pylypenko, Halyna
Fox, Christopher
Thirman, Michael
Campbell, Philip
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25) : 2425 - 2437
[6] Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
Byrd, John C.
Harrington, Bonnie
O'Brien, Susan
Jones, Jeffrey A.
Schuh, Anna
Devereux, Steve
Chaves, Jorge
Wierda, William G.
Awan, Farrukh T.
Brown, Jennifer R.
Hillmen, Peter
Stephens, Deborah M.
Ghia, Paolo
Barrientos, Jacqueline C.
Pagel, John M.
Woyach, Jennifer
Johnson, Dave
Huang, Jane
Wang, Xiaolin
Kaptein, Allard
Lannutti, Brian J.
Covey, Todd
Fardis, Maria
McGreivy, Jesse
Hamdy, Ahmed
Rothbaum, Wayne
Izumi, Raquel
Diacovo, Thomas G.
Johnson, Amy J.
Furman, Richard R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04) : 323 - 332
[7] Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
Byrd, John C.
Furman, Richard R.
Coutre, Steven E.
Flinn, Ian W.
Burger, Jan A.
Blum, Kristie A.
Grant, Barbara
Sharman, Jeff P.
Coleman, Morton
Wierda, William G.
Jones, Jeffrey A.
Zhao, Weiqiang
Heerema, Nyla A.
Johnson, Amy J.
Sukbuntherng, Juthamas
Chang, Betty Y.
Clow, Fong
Hedrick, Eric
Buggy, Joseph J.
James, Danelle F.
O'Brien, Susan
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (01) : 32 - 42
[8] Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
Calin, GA
Dumitru, CD
Shimizu, M
Bichi, R
Zupo, S
Noch, E
Aldler, H
Rattan, S
Keating, M
Rai, K
Rassenti, L
Kipps, T
Negrini, M
Bullrich, F
Croce, CM
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) : 15524 - 15529
[9] Mechanisms of disease: Chronic lymphocytic leukemia
Chiorazzi, N
Rai, KR
Ferrarini, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) : 804 - 815
[10] Corneth OB, 2017, ARTHRITIS RHEUMATOL

← 1 2 3 →